INS and cancer: Several antidiabetic medications such as insulin, sulfonylureas, dipeptyl peptidase (DPP) 4 inhibitors and glucose-dependent insulinotropic peptide (GLP-1) analogues have been shown to increase the risk of different cancers in diabetic patients [81].